Live Breaking News & Updates on Global Oncology

Stay updated with breaking news from Global oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sumitomo Pharma : Posted Conference on FY2023 Financial Results

May 14, 2024

Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including. ....

Toru Kimura , Tsutomu Nakagawa , Hisayoshi Kashima , Motoyuki Sakaibirthdate , Hiroshi Niinuma , Takashi Kutsunai , Minoru Usui , Motoyuki Sakai , Yoshio Iteya , Saeko Arai , Nobuhiro Endo , Mayumi Mochizuki , Koji Fujimoto , Daishiro Michimori , Hiroshi Nomura , School Of Science , Sumitomo Pharma America Inc , Senior Executive Research , Chemical Co Ltd , Kyoto University , Regenerative Cellular Medicine Office , Corporate Communications , Affairs Dept , Co Ltd , Sumitomo Pharmaceuticals Co Ltd , Sumitomo Chemical Co Ltd ,

Sumitomo Pharma : Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers

Sumitomo Pharma : Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Takashi Kutsunai , Saeko Arai , Hiroshi Nomura , Hiroshi Niinuma , Motoyuki Sakaibirthdate , Motoyuki Sakai , Mayumi Mochizuki , Toru Kimura , Minoru Usui , Nobuhiro Endo , Tsutomu Nakagawa , Yoshio Iteya , Daishiro Michimori , Koji Fujimoto , Hisayoshi Kashima , Affairs Dept , Cellular Medicine Kobe Center , Regenerative Cellular Medicine Kobe Center , Sumitomo Chemical Asia Pte Ltd , Sumitomo Chemical Co Ltd , Development Strategy , Global Oncology Of The Company , Corporate Communications , Corporate Planning Coordination Office , Sumitomo Pharma Co Ltd , Drug Research ,

Lupin appoints former executives from two major American companies, as independent directors to its board

Lupin appoints former executives from two major American companies, as independent directors to its board
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

United States , Alfonso Chito Zulueta , Jeffrey Kindler , Eli Lilly , Zuellig Pharma , Vinita Gupta , Terns Pharmaceuticals , Mcdonald Corporation , European Federation Of Pharmaceutical Industries , Payday Solutions , Drugmaker Lupin Ltd , Precigen Inc , Us Japan Business Council , Interpharma Investments Ltd , Perrigo Pharmaceuticals , Chief Executive Officer , General Electric Company , Centrexion Therapeutics , Senior Advisor , Operating Partner , Global Chair , Global Marketing , Global Oncology , Critical Care Products , European Federation , Pharmaceutical Industries ,

Lupin : May 9, 2024 Jeffrey Kindler and Alfonso Zulueta Join Lupin Board as Independent Directors

Lupin : May 9, 2024 Jeffrey Kindler and Alfonso Zulueta Join Lupin Board as Independent Directors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , South Africa , Northern Samar , Asia Pacific , Eli Lilly , Alfonso Chito Zulueta , Zuellig Pharma , Williams Connolly , Vinita Gupta , Jeffrey Kindler , Company Executive Committee , Lupin Limited , Salle University , Us Japan Business Council , Payday Solutions , Mcdonald Corporation , Perrigo Pharmaceuticals , Darden School Of Business , Precigen Inc , Interpharma Investments , European Federation Of Pharmaceutical Industries , University Of Virginia , Tufts University , Biotechnology Pharmaceuticals , Harvard Law School , Terns Pharmaceuticals ,

EMA Validates Frontline Nivolumab Plus Ipilimumab for MSI-H/dMMR mCRC

The European Medicines Agency has validated an application for nivolumab plus ipilimumab for frontline MSI-H/dMMR metastatic colorectal cancer. ....

Dana Walker , Van Cutsem , Bristol Myers Squibb , European Medicines Agency , Medicines Agency , Global Oncology , Colorectal Cancer ,